clinical trial · NCT06622941
Study to ONO-4538 in Patients With Rhabdoid Tumor
Ono Pharmaceutical Co., Ltd.·phase2·recruiting·n = 23
Rhabdoid TumorONO-4538
brief summary
Investigate the efficacy and safety of ONO-4538 for the treatment of rhabdoid Tumors
started
Nov 25, 2024
primary completion
Jan 31, 2029
completion
Mar 31, 2030
last updated
Mar 12, 2026
official title
A Multicenter, Open-label, Uncontrolled Phase II Study to Investigate Efficacy and Safety of ONO4538 in Patients With Rhabdoid Tumor
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol